• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number NVTR-27
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Aortic Valve Stenosis (1717)
Date of Event 09/23/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Clinical information: crd 1003 - vantage, patient site id: (b)(6), (b)(4).It was reported that on (b)(6) 2025, a 27mm navitor valve was chosen for implant using a large flexnav delivery system.The valve was successfully implanted.On (b)(6) 2025, a significant increase in the mean trans prosthetic gradient (25mmhg) was noted.The leaflet appeared to be slightly thickened.A suspected thrombus on the valve.A transthoracic echocardiogram (tte) was scheduled in one month.There was no treatment required.The patient was reported in stable condition.
 
Additional Manufacturer Narrative
The device remains implanted in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of leaflet thickening aortic stenosis and thrombus was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the available information, the cause of the reported aortic stenosis is likely a cascading effect of the reported thrombus formation and thickened leaflet.However, the cause of the reported thrombus formation and thickened leaflet could not be conclusively determined.The reported serious injury/illness/impairment was a result of case-specific circumstances as no intervention was reported.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVITOR TRANSCATHETER AORTIC VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23323079
Report Number2135147-2025-05892
Device Sequence Number13246391
Product Code NPT
UDI-Device Identifier05415067031594
UDI-Public(01)05415067031594(17)260910
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
P190023
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/10/2026
Device Model NumberNVTR-27
Device Catalogue NumberNVTR-27
Device Lot Number10022876
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/24/2025
Supplement Date Received by Manufacturer12/05/2025
Initial Report FDA Received Date10/17/2025
Supplement Report FDA Received Date12/12/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/11/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age81 YR
Patient SexMale
Patient Weight81 KG
-
-